Andreas Halvorsen's position in Royalty Pharma plc is currently worth $373 Million. That's 1.10% of their equity portfolio (31st largest holding). The investor owns 1.90% of the outstanding Royalty Pharma plc stock. The first Royalty Pharma plc trade was made in Q2 2020. Since then Andreas Halvorsen bought shares twelve more times and sold shares on seven occasions. The investor's estimated purchase price is $414 Million, resulting in a loss of 10.0%.